Steven Salamon

Rosalind Advisors, Inc.

Assets Managed

$248.888M

Holdings

Last Quarter

2026 - Q1

Filed Date

1mo 1d ago

Growth Rate

-12.52%(2Q avg: -7.63%)

Sustained Growth

0 quarters

Portfolio positions

This chart displays the top 10 holdings in Rosalind Advisors, Inc.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 38 positions.

Assets under management

The assets under management (AUM) of Rosalind Advisors, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 248.888M in assets, with a quarterly growth rate of -12.52% and a 2-quarter average growth rate of -7.63%. The portfolio is managed by Steven Salamon, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
DCTH Delcath Systems Inc Recent Activity	12.31%	$30.628M 3.3M shares@ $9.29 avg price
XERS Xeris Biopharma Holdings Inc Recent Activity Increased 53.04%	7.54%	$18.744M 3.232M shares@ $5.8 avg price	Increased 53.04%
FENC Fennec Pharmaceuticals Inc Recent Activity Increased 11.28%	7.19%	$17.885M 2.908M shares@ $6.15 avg price	Increased 11.28%
SVRA Savara Inc Recent Activity Decreased -5.87%	7.03%	$17.492M 3.204M shares@ $5.47 avg price	Decreased -5.87%
PCVX Vaxcyte Inc Recent Activity New Position	6.78%	$16.852M 290,000 shares@ $58.11 avg price	New Position
EYPT Eyepoint Pharmaceuticals Inc Recent Activity Increased 50.26%	5.37%	$13.364M 1.037M shares@ $12.9 avg price	Increased 50.26%
XFOR X4 Pharmaceuticals Inc Recent Activity Increased 23.37%	5.34%	$13.277M 3.215M shares@ $4.14 avg price	Increased 23.37%
VOR Vor Biopharma Inc Recent Activity New Position	5.02%	$12.488M 700,000 shares@ $17.84 avg price	New Position
MDWD Mediwound Ltd Recent Activity	4.85%	$12.067M 749,054 shares@ $16.12 avg price
VSTM Verastem Inc Recent Activity Increased 19.57%	4.56%	$11.334M 2.138M shares@ $5.31 avg price	Increased 19.57%

1-10 of 38